Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1347 |
| Name of the vaccine | LBVE |
| Microbe | Bacteria |
| Disease name | Pneumococcal |
| Name of bacteria | Streptococcus pneumoniae |
| Type of vaccine | Conjugate |
| Nucleic acid content | DNA |
| Age | 6 to 8 weeks |
| Description of the vaccine | Multivalent Pneumococcal conjugate vaccine. |
| Name of the manufacturer | LG Chem |
| Name of the manufacturing country | Korea, Republic of |
| Year of manufacture | 2019 |
| Clinical Phase status | Clinical - Phase 2 |
| Bacterial strain | Gram-positive, facultative anaerobic bacteria. |
| Efficacy | NA |
| Vaccine formulation | NA |
| Dosage | Three injections at 6,10 and 14 weeks of age. |
| Mechanism of action | NA |
| Route of administration | Intramuscular |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | NA |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Combination doses |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NCT03467984 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |